Identification of complement receptor one (CR1) polymorphisms in West Africa

Genes and Immunity

Volumn 1, Issue 5, 2000, Pages 325-329

  Moulds, J M ^a,d   Kassambara, L ^b   Middleton, J J ^a   Baby, M ^b   Sagara, I ^b   Guindo, A ^b   Coulibaly, S ^b   Yalcouye, D ^b   Diallo, D A ^b   Miller, L ^c   Doumbo, O ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF BAMAKO   (Mali)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Blood groups; Complement receptors; Malaria

Indexed keywords

MALIA; PLASMODIUM FALCIPARUM;

BLOOD GROUP ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR;

ARTICLE; CHEMISTRY; ERYTHROCYTE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; HUMAN; IMMUNOLOGY; MALARIA FALCIPARUM; MALE; MALI; MOLECULAR WEIGHT; PARASITOLOGY; PEDIGREE; UNITED STATES;

BLOOD GROUP ANTIGENS; ERYTHROCYTES; FEMALE; GENE FREQUENCY; HUMANS; MALARIA, FALCIPARUM; MALE; MALI; MOLECULAR WEIGHT; PEDIGREE; POLYMORPHISM, GENETIC; RECEPTORS, COMPLEMENT 3B; UNITED STATES;

EID: 0034208250     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363676     Document Type: Article

References (24)

1. Birmingham DJ. Erythrocyte complement receptors. Crit Rev Immunol 1995; 15: 133-154.
2. Soya T, Holers VM, Atkinson JP. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, (C4bp), and decay accelerating factor (DAF). J Immunol 1985; 135: 2661-2667.
3. Holers VM, Chaplin DD, LeyKam JF, Gruner BA, Kumar V, Atkinson JP. Human complement C3b/C4b receptor (CR1) mRNA polymorphism that correlates with the CR1 allelic molecular weight polymorphism. Proc Natl Acad Sci 1987; 84: 2459-2463.
4. Wilson JG, Murphy EE, Wong WW, Klickstein LB, Weis JH, Fearon DT. Identification of a restriction fragment polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J Exp Med 1986; 164: 50-59.
5. Herrera AH, Xiang L, Martin SG, Lewis J, Wilson JG. Analysis of complement receptor type 1 (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations. Clin Immunol Immunopath 1998; 87: 176-183.
6. Currie MS, Vala M, Pisetsky DS, Greenberg CS, Crawford J, Cohen HJ. Correlation between erythrocyte CR1 reduction and other blood proteinase markers in patients with malignant and inflammatory disorders. Blood 1990; 75: 1699-1704.
7. Walport MJ, Lachmann PJ. Erythrocyte complement receptor 1, immune complexes, and the rheumatic diseases. Arthritis Rheum 1988; 31: 153-158.
8. Hara T, Kojima A, Fukuda H et al. Levels of complement regulatory proteins CD35 (CR1), CD46 (MCP) and CD55 (DAF) in human haematological malignancies. Br J Haematol 1992; 82: 368-373.
9. Moulds JM, Nickells MW, Moulds JJ, Brown MC, Atkinson JP. The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-Langley, and York blood group sera. J Exp Med 1991; 173: 1159-1163.
10. Rao N, Ferguson DJ, Lee SF, Telen MJ. Identification of human erythrocyte blood group antigens on the C3b/C4b receptor. J Immunol 1991; 146: 3501-3507.
11. a), a high frequency erythrocyte antigen. Transfusion 1970; 10: 737-738.
12. Daniels GL, Anstee DJ, Cartron JP et al. Blood group terminology 1995. ISBT working party on terminology for red cell surface antigens. Vox Sang 1995; 69: 265-279.
13. Moulds JM, Moulds JJ, Brown MC, Atkinson JP. Antiglobulin testing for CR1-related (Knops/McCoy/Swain-Langley/York) blood group antigens: negative and weak reactions are caused by variable expression of CR1. Vox Sang 1992; 62: 230-235.
14. Rowe JA, Moulds JM, Newbold CI, Miller LH. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 1997; 388: 292-295.
15. d. Med Lab Sci 1983; 40: 113-121.
16. Rowe A, Obeiro J, Newbold CI, Marsh K. Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun 1995; 63: 2323-2326.
17. Klickstein LB, Moulds JM. CR1. In: Morley BJ, Walport MJ (eds). The Complement Facts Book. Academic Press: New York, pp 136-145.
18. Wong WW, Farrell SA. Proposed structure of the F' allotype of human CR1. Loss of a C3b binding site may be associated with altered function. J Immunol 1991; 146: 656-662.
19. Van Dyne S, Holers MV, Lublin DM et al. The polymorphism of the C3b/C4b receptor in the normal population and in patients with systemic lupus erythematosus. Clin Exp Immunol 1987; 68: 570-579.
20. Moulds JM, Reveille JD, Arnett FC. Structural polymorphisms of complement receptor 1 (CR1) in systemic lupus erythematosus (SLE) patients and normal controls of three ethnic groups. Clin Exp Immunol 1996; 105: 302-305.
21. Molthan L. The serology of the York-Cost-McCoy-Knops red blood cell system. Am J Med Tech 1983; 49: 49-56.
22. a (Knops). Transfusion 1978; 18: 566-568.
23. Miller L. Impact of malaria on genetic polymorphism and genetic diseases in Africans and African Americans. Proc Natl Acad Sci 1994; 91: 2415-2419.
24. Moulds JM, Brai M, Cohen J et al. Reference typing report for complement receptor 1 (CR1). Exp Clin Immunogenet 1998; 15: 291-294.